25 October 2017 - Deborah Wilkes
Archived
Novartis is transferring several ophthalmic OTC products to its Alcon eyecare division with effect from 1 January 2018. The news comes as the Swiss healthcare company carries out a strategic review of Alcon.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.